Archive.fm

Biotech 2050 Podcast

27. Harnessing the microbiome to combat type 2 diabetes: Colleen Cutcliffe, CEO, Pendulum

Colleen Cutcliffe is the CEO and Co-Founder of Pendulum. She has over 15 years of experience leading and managing biology teams in academia, pharmaceuticals and biotechnology. Prior to starting Pendulum, Colleen was the Senior Manager of Biology at Pacific Biosciences and a Scientist at Elan Pharmaceuticals. Colleen received her Ph.D. in Biochemistry and Molecular Biology from Johns Hopkins University and her B.A. in Biochemistry from Wellesley College.

Broadcast on:
26 Aug 2020